MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/jgid.jgid_142_25

Медицинская библиотека · Journal of global infectious diseases · 2026

Post-COVID-19 Condition has High Prevalence in Patients with Immune-mediated Inflammatory Diseases and Negatively Impacts Quality of Life.

Schlosser Tobias, Krasselt Marco, Hecker Martin, Holler Babett, Hoffmeister Albrecht

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Pandemic situation by severe acute respiratory syndrome coronavirus 2 and the associated disease (coronavirus disease 2019 [COVID-19]) presents broad challenges. Post-COVID-19 condition represents a continuum of persistent symptoms following the acute course. The World Health Organization (WHO) proposes a definition with at least one symptom persisting for 3 months postonset. Negative affection toward quality of life (QoL) is frequently reported. Patients with immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel disease (IBD) and rheumatic diseases (RDs) are of scientific interest as immunologic factors and immunosuppressive therapy might influence QoL in post-COVID-19 conditions.

METHODS

Adult IMID patients (≥18 years) were offered participation in this study at our university outpatient center. Data collection was questionnaire-based and recorded individual COVID-19 history and persisting symptoms. QoL has been assessed by several standardized and validated patient-reported outcome measures (Short IBD Questionnaire and Patient Health Questionnaire 4, 5Q-5D-5L).

RESULTS

A total of 156 patients were included (117 [75%] with IBD, 39 [25%] with RDs). Eighty-one patients (51%) reported a positive COVID-19 history, mostly with mild courses. Only two (2%) required hospitalization, one requiring intensive care. Seven (9%) reported no symptoms, while 20 (25%) met the WHO criterion for post-COVID-19 condition; 19 (23%) were still suffering from post-COVID-19 at the time of data acquisition. Mean/median global QoL scores (scale from 0 [=lowest] to 100 [=highest]) were 71.5/75 in patients without post-COVID-19, compared to 61.9/60 in those with the condition. A one-sided t-test showed a significant association between post-COVID-19 and lower QoL (P = 0.03).

CONCLUSIONS

A relevant fraction of IMID patients suffered from post-COVID-19 condition. This condition negatively impacted the individual QoL.

Для цитирования: Schlosser Tobias, Krasselt Marco, Hecker Martin, Holler Babett, Hoffmeister Albrecht. Post-COVID-19 Condition has High Prevalence in Patients with Immune-mediated Inflammatory Diseases and Negatively Impacts Quality of Life.. Journal of global infectious diseases. 2026. DOI: 10.4103/jgid.jgid_142_25.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.